122 related articles for article (PubMed ID: 12925815)
1. Combination radiation and adenovirus-mediated P16(INK4A) gene therapy in a murine model for head and neck cancer.
Rhee JG; Li D; O'Malley BW; Suntharalingam M
ORL J Otorhinolaryngol Relat Spec; 2003; 65(3):144-54. PubMed ID: 12925815
[TBL] [Abstract][Full Text] [Related]
2. [Combination of adenovirus p16(INK4A) gene therapy and ionizing radiation for laryngeal squamous cell carcinoma].
Fu YJ; Liu SX; Xian JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):209-11. PubMed ID: 15071918
[TBL] [Abstract][Full Text] [Related]
3. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW
Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844
[TBL] [Abstract][Full Text] [Related]
4. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
[TBL] [Abstract][Full Text] [Related]
5. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.
McNally LR; Rosenthal EL; Zhang W; Buchsbaum DJ
Cancer Gene Ther; 2009 Mar; 16(3):246-55. PubMed ID: 18846112
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
Yoo GH; Piechocki MP; Oliver J; Lonardo F; Zumstein L; Lin HS; Kim H; Shibuya TY; Shehadeh N; Ensley JF
Laryngoscope; 2004 Nov; 114(11):1871-9. PubMed ID: 15510008
[TBL] [Abstract][Full Text] [Related]
7. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy.
Mobley SR; Liu TJ; Hudson JM; Clayman GL
Arch Otolaryngol Head Neck Surg; 1998 Jan; 124(1):88-92. PubMed ID: 9440786
[TBL] [Abstract][Full Text] [Related]
8. [Adenovirus p16(INK4A) gene therapy for laryngeal squamous cell carcinoma].
Liu SX; Tang SQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):35-8. PubMed ID: 12778765
[TBL] [Abstract][Full Text] [Related]
9. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
10. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma targeted chemosensitization.
Figures MR; Wobb J; Araki K; Liu T; Xu L; Zhu H; O'Malley BW; Li D
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):177-83. PubMed ID: 19643248
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D
Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
14. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
Goebel EA; Davidson BL; Graham SM; Kern JA
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
[TBL] [Abstract][Full Text] [Related]
15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
[TBL] [Abstract][Full Text] [Related]
17. Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells.
Takahashi H; Hyakusoku H; Horii C; Takahashi M; Nishimura G; Taguchi T; Kondo N; Sakakibara A; Urata Y; Sano D
Head Neck; 2014 Mar; 36(3):411-8. PubMed ID: 23728900
[TBL] [Abstract][Full Text] [Related]
18. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
Morris JC; Wildner O
Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
[TBL] [Abstract][Full Text] [Related]
19. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
